Natsumi Araya
St. Marianna University School Of Medicine
Kanagawa, Japan
Kanagawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Adult T-cell Leukemia Following Satralizumab Treatment for Neuromyelitis Optica Spectrum Disorder.
Journal: Internal medicine (Tokyo, Japan)
Published: July 30, 2025
Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic intervention.
Journal: Nature communications
Published: November 25, 2024
Virus-induced RGMa expression drives neurodegeneration in HTLV-1-associated myelopathy.
Journal: JCI insight
Published: July 09, 2024
EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy.
Journal: Frontiers in microbiology
Published: February 28, 2023
Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
Journal: Brain : a journal of neurology
Published: August 01, 2022
Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.
Journal: Frontiers in immunology
Published: July 13, 2022
Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated Myelopathy.
Journal: Frontiers in medicine
Published: February 19, 2022
Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan.
Journal: Orphanet journal of rare diseases
Published: June 01, 2021
Last Updated: 09/26/2026